| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.55 | 0.04 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.47 | 0.1 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.25 | 0.4 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.23 | 0.4 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.17 | 0.0006 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.2 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.009 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |